Cargando…

Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors

BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are a rare subtype of soft-tissue sarcoma, derived from a peripheral branch or the sheath of the sciatic nerve, brachial plexus, or sacral plexus. The clinical outcomes for MPNST patients with unresectable or metastatic tumors are dismal,...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyama, Rieko, Kito, Fusako, Takahashi, Mami, Hattori, Emi, Noguchi, Rei, Takai, Yoko, Sakumoto, Marimu, Qiao, Zhiwei, Toki, Shunichi, Sugawara, Masato, Tanzawa, Yoshikazu, Kobayashi, Eisuke, Nakatani, Fumihiko, Iwata, Shintaro, Yoshida, Akihiko, Kawai, Akira, Kondo, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031935/
https://www.ncbi.nlm.nih.gov/pubmed/32099531
http://dx.doi.org/10.1186/s12935-020-1128-z
_version_ 1783499473048043520
author Oyama, Rieko
Kito, Fusako
Takahashi, Mami
Hattori, Emi
Noguchi, Rei
Takai, Yoko
Sakumoto, Marimu
Qiao, Zhiwei
Toki, Shunichi
Sugawara, Masato
Tanzawa, Yoshikazu
Kobayashi, Eisuke
Nakatani, Fumihiko
Iwata, Shintaro
Yoshida, Akihiko
Kawai, Akira
Kondo, Tadashi
author_facet Oyama, Rieko
Kito, Fusako
Takahashi, Mami
Hattori, Emi
Noguchi, Rei
Takai, Yoko
Sakumoto, Marimu
Qiao, Zhiwei
Toki, Shunichi
Sugawara, Masato
Tanzawa, Yoshikazu
Kobayashi, Eisuke
Nakatani, Fumihiko
Iwata, Shintaro
Yoshida, Akihiko
Kawai, Akira
Kondo, Tadashi
author_sort Oyama, Rieko
collection PubMed
description BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are a rare subtype of soft-tissue sarcoma, derived from a peripheral branch or the sheath of the sciatic nerve, brachial plexus, or sacral plexus. The clinical outcomes for MPNST patients with unresectable or metastatic tumors are dismal, and novel therapeutic strategies are required. Although patient-derived cancer cell lines are vital for basic research and preclinical studies, few MPNST cell lines are available from public cell banks. Therefore, the aim of this study was to establish cancer cell lines derived from MPNST patients. METHODS: We used tumor tissues from five patients with MPNSTs, including one derived from a rare bone tissue MPNST. The tumor tissues were obtained at the time of surgery and were immediately processed to establish cell lines. A patient-derived xenograft was also established when a sufficient amount of tumor tissue was available. The characterization of established cells was performed with respect to cell proliferation, spheroid formation, and invasion. The mutation status of actionable genes was monitored by NCC Oncopanel, by which the mutation of 114 genes was assessed by next-generation sequencing. The response to anti-cancer agents, including anti-cancer drugs approved for the treatment of other malignancies was investigated in the established cell lines. RESULTS: We established five cell lines (NCC-MPNST1-C1, NCC-MPNST2-C1, NCC-MPNST3-C1, NCC-MPNST4-C1, and NCC-MPNST5-C1) from the original tumors, and also established patient-derived xenografts (PDXs) from which one cell line (NCC-MPNST3-X2-C1) was produced. The established MPNST cell lines proliferated continuously and formed spheroids while exhibiting distinct invasion abilities. The cell lines had typical mutations in the actionable genes, and the mutation profiles differed among the cell lines. The responsiveness to examined anti-cancer agents differed among cell lines; while the presence of an actionable gene mutation did not correspond with the response to the anticipated anti-cancer agents. CONCLUSION: The established cell lines exhibit various characteristics, including proliferation and invasion potential. In addition, they had different mutation profiles and response to the anti-cancer agents. These observations suggest that the established cell lines will be useful for future research on MPNSTs.
format Online
Article
Text
id pubmed-7031935
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70319352020-02-25 Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors Oyama, Rieko Kito, Fusako Takahashi, Mami Hattori, Emi Noguchi, Rei Takai, Yoko Sakumoto, Marimu Qiao, Zhiwei Toki, Shunichi Sugawara, Masato Tanzawa, Yoshikazu Kobayashi, Eisuke Nakatani, Fumihiko Iwata, Shintaro Yoshida, Akihiko Kawai, Akira Kondo, Tadashi Cancer Cell Int Primary Research BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) are a rare subtype of soft-tissue sarcoma, derived from a peripheral branch or the sheath of the sciatic nerve, brachial plexus, or sacral plexus. The clinical outcomes for MPNST patients with unresectable or metastatic tumors are dismal, and novel therapeutic strategies are required. Although patient-derived cancer cell lines are vital for basic research and preclinical studies, few MPNST cell lines are available from public cell banks. Therefore, the aim of this study was to establish cancer cell lines derived from MPNST patients. METHODS: We used tumor tissues from five patients with MPNSTs, including one derived from a rare bone tissue MPNST. The tumor tissues were obtained at the time of surgery and were immediately processed to establish cell lines. A patient-derived xenograft was also established when a sufficient amount of tumor tissue was available. The characterization of established cells was performed with respect to cell proliferation, spheroid formation, and invasion. The mutation status of actionable genes was monitored by NCC Oncopanel, by which the mutation of 114 genes was assessed by next-generation sequencing. The response to anti-cancer agents, including anti-cancer drugs approved for the treatment of other malignancies was investigated in the established cell lines. RESULTS: We established five cell lines (NCC-MPNST1-C1, NCC-MPNST2-C1, NCC-MPNST3-C1, NCC-MPNST4-C1, and NCC-MPNST5-C1) from the original tumors, and also established patient-derived xenografts (PDXs) from which one cell line (NCC-MPNST3-X2-C1) was produced. The established MPNST cell lines proliferated continuously and formed spheroids while exhibiting distinct invasion abilities. The cell lines had typical mutations in the actionable genes, and the mutation profiles differed among the cell lines. The responsiveness to examined anti-cancer agents differed among cell lines; while the presence of an actionable gene mutation did not correspond with the response to the anticipated anti-cancer agents. CONCLUSION: The established cell lines exhibit various characteristics, including proliferation and invasion potential. In addition, they had different mutation profiles and response to the anti-cancer agents. These observations suggest that the established cell lines will be useful for future research on MPNSTs. BioMed Central 2020-02-19 /pmc/articles/PMC7031935/ /pubmed/32099531 http://dx.doi.org/10.1186/s12935-020-1128-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Oyama, Rieko
Kito, Fusako
Takahashi, Mami
Hattori, Emi
Noguchi, Rei
Takai, Yoko
Sakumoto, Marimu
Qiao, Zhiwei
Toki, Shunichi
Sugawara, Masato
Tanzawa, Yoshikazu
Kobayashi, Eisuke
Nakatani, Fumihiko
Iwata, Shintaro
Yoshida, Akihiko
Kawai, Akira
Kondo, Tadashi
Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors
title Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors
title_full Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors
title_fullStr Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors
title_full_unstemmed Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors
title_short Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors
title_sort establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031935/
https://www.ncbi.nlm.nih.gov/pubmed/32099531
http://dx.doi.org/10.1186/s12935-020-1128-z
work_keys_str_mv AT oyamarieko establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT kitofusako establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT takahashimami establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT hattoriemi establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT noguchirei establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT takaiyoko establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT sakumotomarimu establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT qiaozhiwei establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT tokishunichi establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT sugawaramasato establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT tanzawayoshikazu establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT kobayashieisuke establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT nakatanifumihiko establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT iwatashintaro establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT yoshidaakihiko establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT kawaiakira establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors
AT kondotadashi establishmentandcharacterizationofpatientderivedcancermodelsofmalignantperipheralnervesheathtumors